Abiraterone acetate, an efficacy treatment option for metastatic castration-resistant prostate carcinoma (mCRPC) that improves functional status in elderly patients (EP)
Titel:
Abiraterone acetate, an efficacy treatment option for metastatic castration-resistant prostate carcinoma (mCRPC) that improves functional status in elderly patients (EP)
Auteur:
Fratino⁎ , L. Re, G. Lo Polesel, J. Channoufi, L. Muggia, M. Depangher, V. Bearz, A. Spina, M. Tirelli, U.